Systemic Sclerosis (SSc) is a connective tissue disorder featuring vascular alterations and an immunological activation leading to a progressive and widespread fibrosis of several organs such as the skin, lung, gastrointestinal tract, heart, and kidney. Men with SSc are at increased risk of developing erectile dysfunction (ED) because of the evolution of early microvascular tissutal damage into corporeal fibrosis. The entity of penile vascular damage in SSc patients has been demonstrated by using Duplex ultrasonography and functional infra-red imaging and it is now clear that this is a true clinical entity invariably occurring irrespective of age and disease duration and constituting the ''sclerodermic penis". Once-daily phosphodiesterase type-5 (PDE5) inhibitors improve both sexual function and vascular measures of cavernous arteries by improving surrogate markers of endothelial dysfunction, that is, plasma endothelin-1 and adrenomedullin levels, which may play a potential role in preventing progression of penile fibrosis and ED. Also, the beneficial effect of long-term PDE5i add-on therapy to SSc therapy in the treatment of Raynaud's phenomenon is described.

Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects / Aversa, Antonio; Roberto, Bruzziches; Francomano, Davide; Rosato, Edoardo; Salsano, Felice; Spera, Giovanni. - In: INTERNATIONAL JOURNAL OF RHEUMATOLOGY. - ISSN 1687-9260. - STAMPA. - 2010:(2010), p. 708067. [10.1155/2010/708067]

Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

AVERSA, Antonio;FRANCOMANO, DAVIDE;ROSATO, Edoardo;SALSANO, Felice;SPERA, Giovanni
2010

Abstract

Systemic Sclerosis (SSc) is a connective tissue disorder featuring vascular alterations and an immunological activation leading to a progressive and widespread fibrosis of several organs such as the skin, lung, gastrointestinal tract, heart, and kidney. Men with SSc are at increased risk of developing erectile dysfunction (ED) because of the evolution of early microvascular tissutal damage into corporeal fibrosis. The entity of penile vascular damage in SSc patients has been demonstrated by using Duplex ultrasonography and functional infra-red imaging and it is now clear that this is a true clinical entity invariably occurring irrespective of age and disease duration and constituting the ''sclerodermic penis". Once-daily phosphodiesterase type-5 (PDE5) inhibitors improve both sexual function and vascular measures of cavernous arteries by improving surrogate markers of endothelial dysfunction, that is, plasma endothelin-1 and adrenomedullin levels, which may play a potential role in preventing progression of penile fibrosis and ED. Also, the beneficial effect of long-term PDE5i add-on therapy to SSc therapy in the treatment of Raynaud's phenomenon is described.
2010
01 Pubblicazione su rivista::01a Articolo in rivista
Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects / Aversa, Antonio; Roberto, Bruzziches; Francomano, Davide; Rosato, Edoardo; Salsano, Felice; Spera, Giovanni. - In: INTERNATIONAL JOURNAL OF RHEUMATOLOGY. - ISSN 1687-9260. - STAMPA. - 2010:(2010), p. 708067. [10.1155/2010/708067]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/381995
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 8
  • ???jsp.display-item.citation.isi??? ND
social impact